Immunogen reported $5.5M in Stock for its fiscal quarter ending in September of 2023.



Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Amgen USD 6.22B 121M Dec/2025
Astellas Pharma JPY 297.26B 9.92B Mar/2025
AstraZeneca USD 6.59B 126M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Exelixis USD 27.4M 3.92M Sep/2025
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 7.91M 840K Dec/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025